News
2d
The Independent on MSNNine small health issues that might be an early sign of lung cancerNine small health issues that might be an early sign of lung cancer - As the NHS offers ‘revolutionary’ blood test, here are ...
Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...
Three years ago, before I learned that I had metastatic cancer, doctors repeatedly told me I was “too young” to be seriously ...
This weekend is graduation at Stanford. The keynote for Saturday’s medical school ceremony is a Stanford doctor, professor and now patient. Dr. Bryant Lin is fighting stage four lung cancer.
Lung cancer is one of the most frequently diagnosed cancers and the leading cause of cancer-related deaths worldwide with an estimated 2 million new cases and 1·76 million deaths per year. Substantial ...
Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer ...
5d
MedPage Today on MSNNext-Generation TKI Approved for Advanced ROS1-Positive Lung CancerThe FDA approved taletrectinib (Ibtrozi)-- a next-generation oral ROS1 tyrosine kinase inhibitor (TKI) -- for the treatment ...
Which of these comments is not like the others? Learn how to support someone with lung cancer. It can be hard to find the right words when someone you know and love tells you they’ve been ...
The MHRA has approved aumolertinib for adult patients with non-small cell lung cancer (NSCLC), following a groundbreaking ...
COCOON dermatologic management lessened skin side effects and improved quality of life versus standard care for patients with ...
Asandeutertinib is a derivative of Tagrisso designed to avoid certain toxic side effects in patients with EGFR-mutated NSCLC.
Perspective from Charu Aggarwal, MD, MPH, FASCO CHICAGO — A 14-gene molecular assay could help predict which patients with early-stage non-small cell lung cancer will benefit from adjuvant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results